We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
-3.36%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$162M
AUM Growth
-$41.7M
(-20%)
Cap. Flow
-$37.4M
Cap. Flow
% of AUM
-22.99%
Top 10 Holdings %
Top 10 Hldgs %
67.12%
Holding
128
New
40
Increased
32
Reduced
13
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dropbox
DBX
|
+$1.92M |
| 2 |
SNCR
Synchronoss Technologies
SNCR
|
+$1.8M |
| 3 |
EGIO
Edgio, Inc. Common Stock
EGIO
|
+$1.62M |
| 4 |
Silicom
SILC
|
+$1.38M |
| 5 |
CYBE
Cyberoptics Corp
CYBE
|
+$1.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$3.25M |
| 2 |
ON Semiconductor
ON
|
+$1.95M |
| 3 |
Nutanix
NTNX
|
+$1.56M |
| 4 |
FLNA
Filana Therapeutics
FLNA
|
+$1.22M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$1.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.04% |
| 2 | Healthcare | 6.42% |
| 3 | Industrials | 2.39% |
| 4 | Consumer Discretionary | 1% |
| 5 | Communication Services | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BDSI
26
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $551K | 0.34% |
145,550
+12,500
| +9% | +$61.4K |
|
27
Larimar Therapeutics
LRMR
$403M
| $550K | 0.34% |
59,468
+14,270
| +32% | +$188K |
|
28
State Street SPDR S&P Biotech ETF
XBI
$9.62B
| $545K | 0.34% |
7,044
+972
| +16% | +$86.1K |
|
29
Rigel Pharmaceuticals
RIGL
$681M
| $520K | 0.32% |
33,339
+32,073
| +2,533% | +$683K |
|
|
ALIM
30
DELISTED
Alimera Sciences
ALIM
| $509K | 0.31% |
127,333
+28,000
| +28% | +$170K |
|
31
Argan
AGX
$8.07B
| $496K | 0.31% |
10,327
+58
| +0.6% | +$2.4K |
|
32
A10 Networks
ATEN
$2.13B
| $488K | 0.3% |
78,590
+2,800
| +4% | +$17.9K |
|
33
Smith Micro Software
SMSI
$14.4M
| $483K | 0.3% |
+2,865
| New | +$570K |
|
34
Vanguard Information Technology ETF
VGT
$140B
| $481K | 0.3% |
18,176
-1,872
| -9% | -$56.7K |
|
35
Quantum Corp
QMCO
$421M
| $468K | 0.29% |
+7,946
| New | +$714K |
|
|
ADMS
36
DELISTED
Adamas Pharmaceuticals
ADMS
| $454K | 0.28% |
+157,142
| New | +$704K |
|
37
TechTarget
TTGT
$341M
| $452K | 0.28% |
21,908
+3,771
| +21% | +$89.6K |
|
|
AVDL
38
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
| $447K | 0.28% |
+267,500
| New | +$2.05M |
|
|
OPTN
39
DELISTED
OptiNose
OPTN
| $444K | 0.27% |
+6,591
| New | +$664K |
|
40
Annovis Bio
ANVS
$75.7M
| $432K | 0.27% |
+143,750
| New | +$708K |
|
41
Organogenesis Holdings
ORGO
$306M
| $393K | 0.24% |
121,858
-46,142
| -27% | -$198K |
|
42
DHI Group
DHX
$182M
| $392K | 0.24% |
181,270
+20,781
| +13% | +$55.7K |
|
|
FARO
43
DELISTED
Faro Technologies
FARO
| $388K | 0.24% |
8,718
+4,004
| +85% | +$208K |
|
|
LJPC
44
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $358K | 0.22% |
85,425
+53,927
| +171% | +$341K |
|
45
CALL
Ross Stores
ROST
$82B
| $356K | 0.22% |
+19,500
| New | +$2.08M |
|
46
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.9B
| $320K | 0.2% |
6,536
-2,546
| -28% | -$150K |
|
47
DiaMedica Therapeutics
DMAC
$343M
| $296K | 0.18% |
105,842
-16,314
| -13% | -$67.4K |
|
48
ClearPoint Neuro
CLPT
$461M
| $290K | 0.18% |
80,911
-5,814
| -7% | -$28.6K |
|
49
State Street Financial Select Sector SPDR ETF
XLF
$58B
| $290K | 0.18% |
13,920
+4,717
| +51% | +$130K |
|
50
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$803B
| $284K | 0.17% |
+124,500
| New | +$38M |
|
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q1 2020 Portfolio in Review
As of Q1 2020, Worth Venture Partners held 128 positions worth $162M, down 20% from $204M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Worth Venture Partners withdrew a net $37.4M in Q1 2020, closing 25 positions and reducing 13 holdings. Its most notable exit was Teladoc Health, an estimated $3.25M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8% of assets, up from 6.9% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Worth Venture Partners opened a new position in Dropbox worth $1.91M.
- Worth Venture Partners's largest Q1 2020 buy was Dropbox: 105,750 shares worth $1.91M.
- Worth Venture Partners added most to Synchronoss Technologies in Q1 2020, an estimated $1.8M increase.
- Worth Venture Partners's biggest Q1 2020 reduction was Filana Therapeutics, cutting an estimated $1.22M.
- Worth Venture Partners fully exited Teladoc Health in Q1 2020, selling an estimated $3.25M.
- Worth Venture Partners's ten largest holdings make up 67% of its $162M portfolio in Q1 2020.
- Worth Venture Partners opened 40 new positions and closed 25 in Q1 2020.
- Worth Venture Partners's portfolio value fell 20% quarter-over-quarter to $162M.
Based on Worth Venture Partners's 13F filing for Q1 2020, filed 15 May 2020.